Treatment of Neurosarcoidosis with Peripheral Facial (7th) Cranial Nerve Weakness or Acute Sarcoidosis-Associated Aseptic Meningitis
When sarcoidosis involves the nervous system, the peripheral facial nerve is its most common neurologic target. Acute sarcoidosis-associated aseptic meningitis represents a related presentation that may require a similar management approach.
Clinical scenario: Neurosarcoidosis presenting as peripheral facial (7th cranial nerve) weakness, or as acute sarcoidosis-associated aseptic meningitis — the most common neurologic manifestation of this disease.
Treatment approach: A limited course of oral corticosteroid therapy is the first-line approach for this presentation — with the plan adapted based on treatment response. The complete structured regimen, including duration, tapering, and discontinuation criteria, is available in the full protocol.
Treatment goal: Resolution of facial nerve weakness.
References
- The most common neurologic manifestation of neurosarcoidosis is peripheral facial nerve palsy.
- A similar course may be sufficient to treat patients with an acute sarcoidosis-associated aseptic meningitis.
- A limited course of prednisone 20-40 mg daily is recommended for these patients.
- The dosage should be tapered over 1-6 months and can be discontinued if weakness resolves.
View source ↗